Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10
Titel:
Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10
Auteur:
Kienle, Dirk L. Dietrich, Daniel Ribi, Karin Wicki, Andreas Quagliata, Luca Winterhalder, Ralph C. Koeberle, Dieter Horber, Daniel Bastian, Sara Kueng, Marc Saletti, Piercarlo Helbling, Daniel Baertschi, Daniela Lugli, Alessandro Bernhard, Juerg Andrieu, Christiane von Moos, Roger